Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Neuromodulation: Devices's Stimulating Growth Market

This article was originally published in Start Up

Executive Summary

According to "Opportunities in Global Medical Devices and Diagnostics," a report recently published by Health Research International that forecasts growth rates in seven major clinical segments and 20 major technology segments, neuromodulation will experience the highest growth rate of all the top-tier segments over the next five years, in excess of 18%. The neuromodulation segment posted sales of approximately $1.7 billion in 2005 and will be worth almost $4 billion in 2010, HRI predicts.

You may also be interested in...



MicroTransponder Inc.

MicroTransponder's MicroStim Pain Management System is a wireless injectable neurostimulator for treating chronic pain. Because it is smaller than implanted spinal cord stimulators, it can be placed outside of the spinal cord nerve and into the peripheral nerves of the arms, legs, and neck. The three components of the system are the Subcutaneous Arrangement of Injectable Neural Transponders unit (an extremely tiny coil injected via a 16-gauge hypodermic needle near the peripheral nerve), an elastic band on the skin containing a larger coil and small battery, and a personal digital assistant or cell phone for the patient to control the stimulation.

Start-Up News September 2007

TheraCardia has a portfolio of natural biopolymers that it will develop for stents; initially, for stent coatings, and soon, a bioabsorbable stent that avoids inflammation and contributes to endothelization, without the need for a drug. Surgeon-founded Aragon Surgical will develop a platform of products to make surgeries faster and safer. Intelect Medical is developing new neurostimulation devices that, it believes, offer advances over the devices of predecessors. It's initial target application is traumatic brain injury.

In Brief October 2006

Short summaries of notable clinical and product news items in the device industry.

Related Content

Topics

Related Companies

Related Deals

UsernamePublicRestriction

Register

MT037430

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel